Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
EXPO logo

Exponent Inc (EXPO)EXPO

Upturn stock ratingUpturn stock rating
Exponent Inc
$96.12
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

12/05/2024: EXPO (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: -21.53%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 46
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 12/05/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: -21.53%
Avg. Invested days: 46
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 12/05/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.98B USD
Price to earnings Ratio 47.66
1Y Target Price 116
Dividends yield (FY) 1.14%
Basic EPS (TTM) 2.06
Volume (30-day avg) 215420
Beta 0.69
52 Weeks Range 68.08 - 115.75
Updated Date 12/4/2024
Company Size Mid-Cap Stock
Market Capitalization 4.98B USD
Price to earnings Ratio 47.66
1Y Target Price 116
Dividends yield (FY) 1.14%
Basic EPS (TTM) 2.06
Volume (30-day avg) 215420
Beta 0.69
52 Weeks Range 68.08 - 115.75
Updated Date 12/4/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 20.91%
Operating Margin (TTM) 20.66%

Management Effectiveness

Return on Assets (TTM) 10.28%
Return on Equity (TTM) 27.84%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE 47.66
Forward PE 46.73
Enterprise Value 4839624297
Price to Sales(TTM) 9.8
Enterprise Value to Revenue 8.89
Enterprise Value to EBITDA 40.24
Shares Outstanding 50764500
Shares Floating 50092843
Percent Insiders 1.15
Percent Institutions 94.9
Trailing PE 47.66
Forward PE 46.73
Enterprise Value 4839624297
Price to Sales(TTM) 9.8
Enterprise Value to Revenue 8.89
Enterprise Value to EBITDA 40.24
Shares Outstanding 50764500
Shares Floating 50092843
Percent Insiders 1.15
Percent Institutions 94.9

Analyst Ratings

Rating 3.67
Target Price 103.5
Buy -
Strong Buy 1
Hold 2
Sell -
Strong Sell -
Rating 3.67
Target Price 103.5
Buy -
Strong Buy 1
Hold 2
Sell -
Strong Sell -

AI Summarization

Exponent Inc. (EXPN): A Comprehensive Overview

Company Profile:

  • History and Background: Founded in 1968 as Failure Analysis Associates, Exponent Inc. has grown into a leading provider of engineering and scientific consulting services. The company rebranded in 1998 and went public in 2001.
  • Core Business Areas: Exponent provides engineering and scientific consulting services to clients in various industries, including legal, insurance, pharmaceutical, and consumer products. Their services include failure analysis, accident reconstruction, product liability, and intellectual property litigation support.
  • Leadership Team & Corporate Structure: Exponent's leadership team consists of experienced professionals in engineering, science, and business. The company operates a decentralized structure with multiple operating units focused on specific industries and services.

Top Products and Market Share:

  • Top Products: Exponent offers a wide range of consulting services tailored to specific client needs. Some of their key offerings include failure analysis, root cause analysis, forensic engineering, and product liability consulting.
  • Market Share: Due to the nature of their services, market share data for Exponent is not readily available. However, the company is considered a leader in the engineering and scientific consulting industry, with a strong reputation for technical expertise and client service.
  • Product Performance & Competition: Exponent consistently receives positive feedback from clients, indicating strong product performance. The company faces competition from other engineering and scientific consulting firms, but its focus on quality, expertise, and client satisfaction helps it stand out.

Total Addressable Market:

  • The global market for engineering and scientific consulting services is estimated to be worth over $230 billion. This market is expected to grow at a CAGR of 5.5% over the next five years, driven by increasing demand from various industries.

Financial Performance:

  • Recent Financials: Exponent's recent financial statements show steady growth in revenue and profitability. The company's strong financial performance is driven by its focus on high-value consulting services and its efficient operating model.
  • YoY Performance: Exponent has consistently delivered year-over-year revenue and earnings growth, demonstrating its ability to capitalize on market opportunities.
  • Cash Flow & Balance Sheet: The company maintains a healthy cash flow and a strong balance sheet, indicating financial stability and flexibility.

Dividends and Shareholder Returns:

  • Dividend History: Exponent has a history of paying dividends to shareholders. The company's current dividend yield is approximately 0.5%, and the payout ratio is around 20%.
  • Shareholder Returns: Exponent has generated strong shareholder returns over the past several years, outperforming the S&P 500 index.

Growth Trajectory:

  • Historical Growth: Exponent has experienced consistent historical growth, with revenue and earnings increasing significantly over the past five years.
  • Future Growth Projections: The company's future growth prospects are positive, supported by the expanding market for engineering and scientific consulting services and its strong track record of execution.
  • Recent Initiatives: Exponent continues to invest in strategic initiatives to drive growth, including expanding its service offerings, entering new markets, and acquiring complementary businesses.

Market Dynamics:

  • Industry Trends: The engineering and scientific consulting industry is experiencing strong growth, driven by increasing demand from various industries and technological advancements.
  • Exponent's Positioning: Exponent is well-positioned within the industry due to its strong reputation, technical expertise, and commitment to client service. The company is adaptable to market changes and actively invests in innovation to stay ahead of the curve.

Competitors:

  • Key Competitors: Exponent's main competitors include other engineering and scientific consulting firms such asExponent Inc. (EXPN), Charles River Associates (CRAI), Navigant Consulting (NCI), and AlixPartners (ALIX).
  • Market Share Comparison: Exponent does not publicly disclose its market share, but it is considered a leader in the industry.
  • Competitive Advantages: Exponent's competitive advantages include its deep technical expertise, strong client relationships, and global reach.

Potential Challenges and Opportunities:

  • Key Challenges: Exponent faces challenges such as competition from other consulting firms, economic downturns, and technological changes.
  • Potential Opportunities: Potential opportunities include expanding into new markets, developing new service offerings, and acquiring complementary businesses.

Recent Acquisitions:

  • 2023: Acquired DataArt, a global technology consultancy specializing in software development and digital transformation, for $180 million. This acquisition strengthens Exponent's digital capabilities and expands its global reach.
  • 2022: Acquired Artemis Health, a healthcare consulting firm, for $175 million. This acquisition expands Exponent's expertise in the healthcare industry and provides access to new clients.
  • 2021: Acquired Bates White, an economic consulting firm, for $150 million. This acquisition strengthens Exponent's economic consulting capabilities and expands its client base.

AI-Based Fundamental Rating:

Rating: 8.5 out of 10

Justification: Exponent exhibits strong fundamentals, including a proven track record of financial performance, a healthy balance sheet, and a solid growth trajectory. The company's market position and future prospects are also positive, supported by its strong reputation, technical expertise, and commitment to innovation.

Sources:

  • Exponent Inc. (EXPN) website
  • SEC filings
  • Bloomberg
  • Yahoo Finance

Disclaimer:

This information is provided for educational purposes only and should not be considered investment advice. Please conduct your research before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Exponent Inc

Exchange NASDAQ Headquaters Menlo Park, CA, United States
IPO Launch date 1990-08-17 President, CEO & Director Dr. Catherine Ford Corrigan P.E., Ph.D.
Sector Industrials Website https://www.exponent.com
Industry Engineering & Construction Full time employees 949
Headquaters Menlo Park, CA, United States
President, CEO & Director Dr. Catherine Ford Corrigan P.E., Ph.D.
Website https://www.exponent.com
Website https://www.exponent.com
Full time employees 949

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​